Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivo

Antonia E. Stephen, Peter T. Masiakos, Dorry L. Segev, Joseph P. Vacanti, Patricia K. Donahoe, David T. MacLaughlin

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivo'. Together they form a unique fingerprint.

Medicine & Life Sciences